Overview

Update
Acquisitions
1 Acquisition
IPO / Stock
Went Public on Apr 11, 2014 / NASDAQ:ADMS
Headquarters:
Emeryville, CA
Description:
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Categories:
Pharmaceutical, Therapeutics, Health Care
Website:
http://www.adamaspharma.com
Social:

Company Details

Update

Adamas Pharmaceuticals, Inc. engages in the development and commercialization of controlled release combination therapeutics to treat healthcare problems, primarily in the areas of infectious diseases and central nervous system disorders. It also develops novel extended release and combination products for symptomatic treatment of dementia. The company was incorporated in 2000 and is headquartered in Emeryville, California with operations in India, the United States, and Singapore.

Funding Rounds (4) - $82M

Update
DateAmount / RoundValuationLead InvestorInvestors
Oct, 2009$40M / Series D4
Jul, 2008$8M / Series C0
Aug, 2007$13M / Series C0
May, 2005$21M / Series B1

Acquisitions (1)

Update
DateAcquiredAmount
Jul 30, 1996Unknown

Current Team (8)

Update

Offices/Locations (1)

Update
  • Headquarters

    1900 Powell Street

    Suite 1050

    Emeryville, CA 94608

    USA

Past Team (3)

Update

Images (1)

Update

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos